PABGX
Price
$185.77
Change
+$0.04 (+0.02%)
Updated
Jan 30 closing price
Net Assets
65.64B
RGACX
Price
$75.98
Change
+$0.67 (+0.89%)
Updated
Jan 30 closing price
Net Assets
309.75B
Ad is loading...

PABGX vs RGACX

Header iconPABGX vs RGACX Comparison
Open Charts PABGX vs RGACXBanner chart's image
T. Rowe Price Blue Chip Growth Advisor
Price$185.77
Change+$0.04 (+0.02%)
VolumeN/A
Net Assets65.64B
American Funds Growth Fund of Amer R3
Price$75.98
Change+$0.67 (+0.89%)
VolumeN/A
Net Assets309.75B
PABGX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PABGX vs. RGACX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABGX is a Buy and RGACX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 310B vs. PABGX (65.6B). RGACX pays higher dividends than PABGX: RGACX (0.25) vs PABGX (0.00). PABGX was incepted earlier than RGACX: PABGX (25 years) vs RGACX (23 years). RGACX is a more actively managed with annual turnover of: 31.00 vs. PABGX (9.80). RGACX has a lower initial minimum investment than PABGX: RGACX (250) vs PABGX (2500). PABGX annual gain was more profitable for investors over the last year : 23.93 vs. RGACX (22.05). RGACX (50.98) and PABGX (48.57) have equivalent 5 years return.
PABGXRGACXPABGX / RGACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years23 years-
Gain YTD3.1885.54258%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets65.6B310B21%
Annual Yield % from dividends0.000.25-
Returns for 1 year23.9322.05109%
Returns for 3 years19.8717.19116%
Returns for 5 years48.5750.9895%
Returns for 10 years175.9981.87215%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZUN3.350.29
+9.48%
Baozun
FORM39.830.86
+2.21%
FormFactor
INDP0.940.02
+1.63%
Indaptus Therapeutics
NTNX68.010.25
+0.37%
Nutanix
HGTY9.74N/A
N/A
Hagerty